217 related articles for article (PubMed ID: 3012224)
1. [Systematic detection of anti-LAV/HTLV-III antibodies in blood donors and hemophiliacs].
Muncunill J; Forteza A; Forner N; Forteza-Rei J
Med Clin (Barc); 1986 Apr; 86(13):565. PubMed ID: 3012224
[No Abstract] [Full Text] [Related]
2. [Preventive measures against HTLV-III/LAV infections among hemophiliacs and their relatives].
Evensen SA; Frøland SS; Glomstein A
Tidsskr Nor Laegeforen; 1986 Jan; 106(1):19-21. PubMed ID: 3006278
[No Abstract] [Full Text] [Related]
3. Prevalence of HTLV-III/LAV antibodies in patients with hemophilia and in their sexual partners in France.
Allain JP
N Engl J Med; 1986 Aug; 315(8):517-8. PubMed ID: 3016541
[No Abstract] [Full Text] [Related]
4. [Anti-HTLV-I antibody and anti-HIV antibody in hemophiliacs, patients with renal disease and blood donors].
Kohno S; Masuyama Y; Dohtsu Y; Miyazaki T; Koga H; Yokoyama K; Taura K; Harada T; Yamaguchi K; Izumikawa K
Kansenshogaku Zasshi; 1987 May; 61(5):567-73. PubMed ID: 2822821
[No Abstract] [Full Text] [Related]
5. Association of HTLV-III antibodies and cellular immune status of hemophiliacs.
Tsoukas C; Gervais F; Shuster J; Gold P; O'Shaughnessy M; Robert-Guroff M
N Engl J Med; 1984 Dec; 311(23):1514-5. PubMed ID: 6095077
[No Abstract] [Full Text] [Related]
6. [The occurrence of LAV/HTLV III antibodies in patients with hemophilia in the County of Funen].
Larsen FS; Høst A; Munk-Andersen G
Ugeskr Laeger; 1986 Mar; 148(14):865-7. PubMed ID: 3010526
[No Abstract] [Full Text] [Related]
7. Correlation of antibodies to LAV/HTLV III in hemophiliacs with the use of virus-inactivated clotting factors.
Dietz B; Klose HJ; Gürtler L; Eberle J; Deinhardt F; Köhler-Vajta K; Peller P
Thromb Haemost; 1986 Aug; 56(1):50-2. PubMed ID: 3095947
[TBL] [Abstract][Full Text] [Related]
8. The prevalence of HTLV-III and HTLV-I antibodies in serum of hemophiliacs.
De Rossi A; Dalla Gassa O; Chieco Bianchi L; Dal Bo Zanon R; Boscaro M; Girolami A
Thromb Haemost; 1985 Dec; 54(4):897. PubMed ID: 3003957
[No Abstract] [Full Text] [Related]
9. Detection of antibodies to human T-lymphotropic viruses type I and III in Japanese hemophiliacs.
Koyanagi Y; Kobayashi S; Harada S; Kikukawa R; Yamamoto N; Watanabe K; Okino F; Kajii T
AIDS Res; 1983-1984; 1(5):353-8. PubMed ID: 6100780
[TBL] [Abstract][Full Text] [Related]
10. Detection of acquired immunodeficiency syndrome (AIDS) retrovirus antibody by lymphadenopathy-associated virus (LAV) enzyme immunoassay in low- and high-risk populations.
Ragni MV; Lewis JH; Bracken M; Toth R; Stokes J; Steffensen DO
Transfusion; 1986; 26(3):299-301. PubMed ID: 3010516
[TBL] [Abstract][Full Text] [Related]
11. LAV/HTLV-III seroconversion and disease in hemophiliacs treated in France.
Mathez D; Leibovitch J; Sultan Y; Maisonneuve P
N Engl J Med; 1986 Jan; 314(2):118-9. PubMed ID: 3079879
[No Abstract] [Full Text] [Related]
12. HTLV-III/LAV antibodies and virus in hemophilia patients in Nebraska: survey and initiation of a prospective study.
Volsky DJ; Wu YT; Sinangil F; Goldsmith JC
AIDS Res; 1986 Feb; 2(1):51-61. PubMed ID: 2424467
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of HTLV-III/LAV antibodies in Italian asymptomatic hemophiliacs given commercial concentrates of factors VIII and IX.
Verani P; Mariani G; Mannucci PM; De Rossi G; Nicoletti L; Titti F; Falcione E; Pasqualetti D; Ammassari M; Gringeri A
J Med Virol; 1986 Jun; 19(2):143-9. PubMed ID: 3014059
[TBL] [Abstract][Full Text] [Related]
14. Viral envelope protein of HTLV-III is the major target antigen for antibodies in hemophiliac patients.
Kitchen L; Malone G; Orgad S; Barin F; Zaizov R; Ramot B; Gazit E; Kreiss J; Leal M; Wichmann I
J Infect Dis; 1986 Apr; 153(4):788-90. PubMed ID: 3005438
[No Abstract] [Full Text] [Related]
15. [Detection of anti-HTLV-III antibodies in hemophiliacs--prevalence rates in Japan and comparison of two assay systems].
Hattori T; Shojiro I; Uchida T; Matsuoka M; Yamamoto S; Hiyoshi Y; Fukutake K; Takatsuki K
Rinsho Ketsueki; 1986 Jul; 27(7):1057-63. PubMed ID: 3465965
[No Abstract] [Full Text] [Related]
16. Immunologic status, granulocyte chemotaxis and antibodies to HTLVIII/LAV in haemophiliacs treated with clotting factor concentrates.
Gamba G; Ippoliti G; Bajani G; Ricevuti G; Mazzone A; Badarida G; Gobbi P; Geroldi D; Ascari E
Haematologica; 1987; 72(2):129-35. PubMed ID: 3040550
[No Abstract] [Full Text] [Related]
17. HTLV-III/LAV-seronegative, virus-negative sexual partners and household contacts of hemophiliacs.
McFadden T; Jason JM; Feorino P
JAMA; 1986 Apr; 255(13):1702. PubMed ID: 3005673
[No Abstract] [Full Text] [Related]
18. Anti-HTLV-III screening of blood donors.
Kühnl P; Seidl S; Holzberger G
Vox Sang; 1986; 51 Suppl 1():15-20. PubMed ID: 3017001
[TBL] [Abstract][Full Text] [Related]
19. [Evaluation of 3 immuno-enzyme kits for the detection of anti-LAV antibodies. Comparison with confirmation tests. Study Subgroup of the National Blood Transfusion Society].
Rev Fr Transfus Immunohematol; 1985 Sep; 28(4):325-44. PubMed ID: 3001897
[TBL] [Abstract][Full Text] [Related]
20. [Anti-HTLV-III in hemophilic patients in Barcelona].
Hernández Sánchez JM; Piqueras J; Vila M; Tusell J; Triginer J
Sangre (Barc); 1985; 30(5):857-63. PubMed ID: 3003939
[No Abstract] [Full Text] [Related]
[Next] [New Search]
